ONO Pharmaceutical Co Ltd
ONO Pharmaceutical Co., Ltd. (ticker: 4528) is a Japanese biopharmaceutical company focused on the discovery, development, and commercialization of innovative drugs. Established in 1717, ONO operates primarily in the pharmaceutical sector, with a strong emphasis on oncology, immunology, and central nervous system disorders. The company's core products include monoclonal antibodies, small molecule drugs, and other therapeutic agents aimed at addressing unmet medical needs.